Hirulog Early Reperfusion/Occlusion Trial - HERO

Description:

The HERO trial was designed to compare the efficacy and safety of low or high dose hirulog, a direct thrombin inhibitor, vs heparin for achieving early and complete flow of the infarct related artery in acute MI patients receiving streptokinase and aspirin.